Influence of human serum on antifungal pharmacodynamics with Candida albicans. - Wikidata - awgldk - TriplyDB

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

http://www.wikidata.org/entity/Q39477738

about

Nonspecific effect of Mycograb on amphotericin B MIC Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents Antifungal Susceptibility in Serum and Virulence Determinants of Candida Bloodstream Isolates from Hong Kong Serum repressing efflux pump CDR1 in Candida albicans.Antimicrobial Activity and Resistance: Influencing Factors.In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model.In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis.The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions Effective concentration-based serum pharmacodynamics for antifungal azoles in a murine model of disseminated Candida albicans infection.An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.Echinocandins: are they all the same?Patterns of amphotericin B killing kinetics against seven Candida species.Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.Posaconazole in human serum: a greater pharmacodynamic effect than predicted by the non-protein-bound serum concentration.In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.Direct comparison of the pharmacodynamics of four antifungal drugs in a mouse model of disseminated candidiasis using microbiological assays of serum drug concentrations.Pharmacology of Systemic Antifungal Agents Glucan Synthase Inhibitors

P2860

Q24632922-1868D2F1-B30B-4F6C-9657-2E56689AC357 Q26827380-876A46AA-B917-4623-B726-D6604CB9CB57 Q28388030-0B9DAC50-C4D8-4048-A817-FD80714A96DB Q33250096-C3930A37-EEAE-4521-BB9F-5B4864AFDF3A Q33790192-8A6DFC8B-FB01-4985-A736-A14904A866B8 Q34253266-6CA34B89-8111-4490-B6CC-137686453687 Q34881676-46A4C248-0DF5-4B10-93F7-58C60C8DBB25 Q35091285-66A178F0-D3D0-4562-9405-8303C84C7DE2 Q36626518-13C74BCC-A6CA-4BE0-B1F4-B0C3BCB73CE5 Q36644611-98CF4A0A-B56D-42A6-8F6B-F72CF051A9F5 Q36757617-5E980C12-13DD-49CE-848F-1B77A8293A0D Q37263780-B11E5EBE-58F0-44BB-8955-A96437715E8B Q37356974-EAFDA0EA-571B-415A-A045-E07F9D68C097 Q37563029-E54AFF35-B8A3-484E-9C6F-5EA89898DDEF Q37568382-7003DE5A-8A62-42F3-8D82-BBA74E54A895 Q37974743-0D222FB6-0012-4AA5-92B5-AB801C48CDA0 Q40968227-41D9F902-9138-461E-92B2-EB3D11565CD4 Q41004012-7FACE8C2-63D0-4EE5-8561-D1E74E190A7B Q42112398-9D892514-26C2-480A-B6A3-89D3F9AD4B5C Q42572410-48E5433D-727F-42FB-AFC2-31063085BC5A Q42676999-3E299120-35F9-45C3-BC1A-9F5D23D33068 Q46882635-B3D4D85C-629B-433D-994B-7130AA27C4A2 Q57533011-2618DD2A-2100-42B5-9A4E-0074268C677D Q58033533-BE271F48-5943-4366-892F-0D68DD322725

P2860

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

http://www.wikidata.org/entity/Q39477738

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

@en

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

@nl

type

label

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

@en

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

@nl

prefLabel

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

@en

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

@nl

P1433

Q39477738-AD8B2AAF-FBC1-4ADF-BF4D-E103CFF539F9

P1476

Q39477738-2FD2E66B-579D-49EE-B9B7-612056C6218A

P2093

Q39477738-2CF46E37-76C9-46CE-8EE9-C1E46E50D752

Q39477738-8CA47039-F280-47DD-AEE3-12980B4AAFF8

Q39477738-AF0109C2-D2D3-44B7-BC6F-B91F9E51EC10

Q39477738-CEB9617A-7DA5-46DB-89F9-FBF18228C9B2

P2860

Q39477738-0BA0353F-D949-4304-A50C-3B4BF1DDF28C

Q39477738-10BE31C9-0649-4918-88A0-DF4F9B40010E

Q39477738-1A4C860B-A260-414A-BFF4-B044106E23FC

Q39477738-1AFA3A17-A4D6-4D3F-BB5D-76726527A8AA

Q39477738-7F14C8F5-F0E5-4913-B8A3-6ACA6F1BCF14

Q39477738-84062280-F2DF-4829-BE8C-2090B7116069

Q39477738-8D2E697A-DF30-459A-8C29-FF0596BC5208

Q39477738-9EE77485-ED03-4ECD-BACA-3959364E539C

Q39477738-A4851D74-406B-4738-8049-B5D190EB5F5A

Q39477738-AEC8D34C-582B-4D27-8AD0-CC942BCE5BC9

P304

Q39477738-5BCA8870-B195-489C-91F4-E977E9B2F532

P31

Q39477738-58D88261-A197-494A-9AA1-72C27D22D7A0

P356

Q39477738-72FFA686-5346-4EB9-A50B-1D1FFF63946F

P407

Q39477738-F310094F-1B5C-49AD-AF76-072CB5128A2E

P433

Q39477738-0EB4FF71-45ED-4C1C-A5B8-037076484A3F

P478

Q39477738-561AF3CC-A20E-4984-AC65-0BA9549AA911

P577

Q39477738-167F6D6A-C5DF-4579-ADFD-D188FE2E3DBA

P5875

Q39477738-CDC8024B-9045-4709-88D2-9AAC8F6E9E66

P698

Q39477738-4EDF2CA2-E951-4105-8F90-02EF35B5778E

P932

Q39477738-5D4E5D68-185D-4839-8F54-DA8210EC44A6

P356

AAC.45.7.2018-2022.2001

P1433

Antimicrobial Agents and Chemotherapy

P1476

Influence of human serum on antifungal pharmacodynamics with Candida albicans.

@en

P2093

D G Saunders

http://www.w3.org/2001/XMLSchema#string

D J Hoban

http://www.w3.org/2001/XMLSchema#string

G G Zhanel

http://www.w3.org/2001/XMLSchema#string

J A Karlowsky

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species

In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species

Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.

Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureus.

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole.

Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus

Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

P304

2018-2022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.45.7.2018-2022.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11932138

http://www.w3.org/2001/XMLSchema#string

P698

11408217

http://www.w3.org/2001/XMLSchema#string

P932

90594

http://www.w3.org/2001/XMLSchema#string